On the one hand, genetic modifications directly affect B cell function; for example, mice with Act1 deficiency (95) and BAFF overexpression (103) spontaneously develop SS-like symptoms, demonstrating that B cell dysregulation could lead to SS-like disease. This evidence concerns the gene TRAF3IP2 and synovial sarcoma.